Hydroxyurea and growth in young children with sickle cell disease

Pediatrics

Volumn 134, Issue 3, 2014, Pages 465-472

  Rana, Sohail ^a   Houston, Patricia E ^a   Wang, Winfred C ^b   Iyer, Rathi V ^c   Goldsmith, Jonathan ^d   Casella, James F ^e   Reed, Caroline K ^a   Rogers, Zora R ^f   Waclawiw, Myron A ^d   Thompson, Bruce ^g  

^a HOWARD UNIVERSITY   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^g Clinical Trials & Surveys Corp   (United States)

Author keywords

BMI; Children; Growth; Head circumference; Height; Hydroxyurea; Sickle cell disease; Weight

Indexed keywords

HYDROXYUREA; PLACEBO; ANTISICKLING AGENT;

ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHILD; CHILD GROWTH; CONTROLLED STUDY; DNA SYNTHESIS; DOUBLE BLIND PROCEDURE; DUBOWITZ SCORE; GROWTH CURVE; GROWTH DISORDER; GROWTH INHIBITION; HEAD CIRCUMFERENCE; HUMAN; KIDNEY FUNCTION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEUTROPHIL COUNT; RANDOMIZED CONTROLLED TRIAL; RETICULOCYTE COUNT; SICKLE CELL ANEMIA; SPLEEN FUNCTION; BMI; BODY SIZE; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; FEMALE; GROWTH; HEIGHT; INFANT; LONGITUDINAL STUDY; MALE; PHYSIOLOGY; PRESCHOOL CHILD; WEIGHT;

BMI; CHILDREN; GROWTH; HEAD CIRCUMFERENCE; HEIGHT; HYDROXYUREA; SICKLE CELL DISEASE; WEIGHT;

ANEMIA, SICKLE CELL; ANTISICKLING AGENTS; BODY SIZE; BODY WEIGHT; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROXYUREA; INFANT; LONGITUDINAL STUDIES; MALE;

EID: 84907218716     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2014-0917     Document Type: Article

References (45)

1. Jimenez CT, Scott RB, Henry HL, Sampson CC, Ferguson AD. Studies in sickle cell anemia. XXVI. The effects of homozygous sickle cell disease on the onset of menarche, pregnancy, fertility, pubescent changes, and body growth in Negro subjects. Am J Dis Child. 1966;111:497-504
2. Scott RB, Ferguson AD, Jenkins ME, Clark HM. Studies in sickle-cell anemia. VIII. Further observations on the clinical manifestations of sickle-cell anemia in children. AMA Am J Dis Child. 1955;90(6):682-691
3. Al-Saqladi AW, Cipolotti R, Fijnvandraat K, Brabin BJ. Growth and nutritional status of children with homozygous sickle cell disease. Ann Trop Paediatr. 2008;28(3):165-189
4. Platt OS, Rosenstock W, Espeland MA. Influence of sickle hemoglobinopathies on growth and development. N Engl J Med. 1984;311(1):7-12
5. Whitten CF. Growth status of children with sickle-cell anemia. Am J Dis Child. 1961;102: 355-364
6. McCormack MK, Dicker L, Katz SH, et al. Growth patterns of children with sickle-cell disease. Hum Biol. 1976;48(3):429-437
7. Lowry MF, Desai P, Ashcroft MT, Serjeant BF, Serjeant GR. Heights and weights of Jamaican children with homozygous sickle cell disease. Hum Biol. 1977;49(3):429-436
8. Luban NLC, Leikin SL, August GA. Growth and development in sickle cell anemia. Preliminary report. Am J Pediatr Hematol Oncol. 1982;4(1):61-65
9. Al-Saqladi AW, Bin-Gadeen HA, Brabin BJ. Growth in children and adolescents with sickle cell disease in Yemen. Ann Trop Paediatr. 2010;30(4):287-298
10. Mukherjee MB, Gangnkhedkar RR. Physical growth of children with sickle cell disease. Indian J Hum Genet. 2004;10:70-72
11. Osei-Yeboah C, Rodrigues O, Enweronu- Laryea C. Nutritional status of children with sickle cell disease at Korle Bu Teaching Hospital, Accra, Ghana. West Afr J Med. 2011;30(4):262-267
12. Thomas PW, Singhal A, Hemmings-Kelly M, Serjeant GR. Height and weight reference curves for homozygous sickle cell disease. Arch Dis Child. 2000;82(3):204-208
13. Silva CM, Viana MB. Growth deficits in children with sickle cell disease. Arch Med Res. 2002;33(3):308-312
14. Singhal A, Thomas P, Cook R, Wierenga K, Serjeant G. Delayed adolescent growth in homozygous sickle cell disease. Arch Dis Child. 1994;71(5):404-408
15. Rhodes M, Akohoue SA, Shankar SM, et al. Growth patterns in children with sickle cell anemia during puberty. Pediatr Blood Cancer. 2009;53(4):635-641
16. Isah HO, Oche MO, Ibrahim KO, Gande-Isa S. Anthropomorphic profiles of homozygous sickle cell children in north-western Nigeria: findings from Usmanu Danfoiyo University Teaching Hospital, Sokoto, Nigeria. Sahel Med Journal. 2008;11(2):45-48
17. Zemel BS, Kawchak DA, Ohene-Frempong K, Schall JI, Stallings VA. Effects of delayed pubertal development, nutritional status, and disease severity on longitudinal patterns of growth failure in children with sickle cell disease. Pediatr Res. 2007;61(5 pt 1):607-613
18. Wang WC, Morales KH, Scher CD, et al; STOP Investigators. Effect of long-term transfusion on growth in children with sickle cell anemia: results of the STOP trial. J Pediatr. 2005;147(2):244-247
19. Wang WC, Helms RW, Lynn HS, et al. Effect of hydroxyurea on growth in children with sickle cell anemia: results of the HUG-KIDS Study. J Pediatr. 2002;140(2):225-229
20. Wali YA, Moheeb H. Effect of hydroxyurea on physical fitness indices in children with sickle cell anemia. Pediatr Hematol Oncol. 2011;28(1):43-50
21. Wang WC, Ware RE, Miller ST, et al; BABY HUG investigators. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). Lancet. 2011;377(9778): 1663-1672
22. Thompson BW, Miller ST, Rogers ZR, et al. The pediatric hydroxyurea phase III clinical trial (BABY HUG): challenges of study design. Pediatr Blood Cancer. 2010;54(2):250-255
23. Grummer-Strawn LM, Reinold C, Krebs NF; Centers for Disease Control and Prevention (CDC). Use of World Health Organization and CDC growth charts for children aged 0- 59 months in the United States. MMWR Recomm Rep. 2010;59(RR-9):1-15
24. World Health Organization. SAS macros. Available at: www.who.int/childgrowth/softward/en/. Accessed July 7, 2014
25. Cole TJ, Green PJ. Smoothing reference centile curves: the LMS method and penalized likelihood. Stat Med. 1992;11(10): 1305-1319
26. Luporini SM, Bendit I, Manhani R, Bracco OL, Manzella L, Giannella-Neto D. Growth hormone and insulin-like growth factor I axis and growth of children with different sickle cell anemia haplotypes. J Pediatr Hematol Oncol. 2001;23(6):357-363
27. Kawchak DA, Schall JI, Zemel BS, Ohene- Frempong K, Stallings VA. Adequacy of dietary intake declines with age in children with sickle cell disease. J Am Diet Assoc. 2007;107(5):843-848
28. Barden EM, Kawchak DA, Ohene-Frempong K, Stallings VA, Zemel BS. Body composition in children with sickle cell disease. Am J Clin Nutr. 2002;76(1):218-225
29. Dekker LH, Fijnvandraat K, Brabin BJ, van Hensbroek MB. Micronutrients and sickle cell disease, effects on growth, infection and vaso-occlusive crisis: a systematic review. Pediatr Blood Cancer. 2012;59(2):211-215
30. Prasad AS. Discovery of human zinc deficiency: 50 years later. J Trace Elem Med Biol. 2012;26(2-3):66-69
31. Cox SE, Makani J, Fulford AJ, et al. Nutritional status, hospitalization and mortality among patients with sickle cell anemia in Tanzania. Haematologica. 2011;96(7):948-953
32. Nunlee-Bland G, Rana SR, Houston-Yu PE, Odonkor W. Growth hormone deficiency in patients with sickle cell disease and growth failure. J Pediatr Endocrinol Metab. 2004;17(4):601-606
33. Borel MJ, Buchowski MS, Turner EA, Peeler BB, Goldstein RE, Flakoll PJ. Alterations in basal nutrient metabolism increase resting energy expenditure in sickle cell disease. Am J Physiol. 1998;274(2 pt 1):E357-E364
34. Akohoue SA, Shankar S, Milne GL, et al. Energy expenditure, inflammation, and oxidative stress in steady-state adolescents with sickle cell anemia. Pediatr Res. 2007;61(2):233-238
35. Hibbert JM, Creary MS, Gee BE, Buchanan ID, Quarshie A, Hsu LL. Erythropoiesis and myocardial energy requirements contribute to the hypermetabolism of childhood sickle cell anemia. J Pediatr Gastroenterol Nutr. 2006;43(5):680-687
36. Fung EB, Barden EM, Kawchak DA, Zemel BS, Ohene-Frempong K, Stallings VA. Effect of hydroxyurea therapy on resting energy expenditure in children with sickle cell disease. J Pediatr Hematol Oncol. 2001;23(9):604-608
37. Ganguly A, Boswell W, Aniq H. Musculoskeletal manifestations of sickle cell anaemia: a pictorial review. Anemia. 2011;2011: 794283
38. Javed F, Correa FO, Nooh N, Almas K, Romanos GE, Al-Hezaimi K. Orofacial manifestations in patients with sickle cell disease. Am J Med Sci. 2013;345(3):234-237
39. Martinoli C, Bacigalupo L, Forni GL, Balocco M, Garlaschi G, Tagliafico A. Musculoskeletal manifestations of chronic anemias. Semin Musculoskelet Radiol. 2011;15(3): 269-280
40. Miller ST, Sleeper LA, Pegelow CH, et al. Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med. 2000; 342(2):83-89
41. Wang WC, Wynn LW, Rogers ZR, Scott JP, Lane PA, Ware RE. A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia. J Pediatr. 2001;139(6): 790-796
42. Morrison F, Shubina M, Turchin A. Encounter frequency and serum glucose level, blood pressure, and cholesterol level control in patients with diabetes mellitus. Arch Intern Med. 2011;171(17):1542-1550
43. Turchin A, Goldberg SI, Shubina M, Einbinder JS, Conlin PR. Encounter frequency and blood pressure in hypertensive patients with diabetes mellitus. Hypertension. 2010; 56(1):68-74
44. Guthmann R, Davis N, Brown M, Elizondo J. Visit frequency and hypertension. J Clin Hypertens (Greenwich). 2005;7(6):327-332
45. Thornburg CD, Rogers ZR, Jeng MR, et al; BABY HUG Investigators. Adherence to study medication and visits: data from the BABY HUG trial. Pediatr Blood Cancer. 2010;54(2): 260-264